Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley Riddell

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Human Gene Therapy|August 10, 2007
Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domainsJinjuan Wang, Michael Jensen, Yukang Lin, et al.
Oncotarget|June 10, 2016
Human HLA-A*02:01/CHM1+ allo-restricted T cell receptor transgenic CD8+ T cells specifically inhibit Ewing sarcoma growth in vitro and in vivoFranziska Blaeschke, Uwe Thiel, Andreas Kirschner, et al.
Molecular Therapy. Oncology|June 27, 2024
Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 <i>in vitro</i> and <i>in vivo</i> in NB xenograftsYaya Chu, Gaurav Nayyar, Meijuan Tian, et al.
Molecular Therapy. Oncology|February 9, 2026
Erratum: Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 <i>in vitro</i> and <i>in vivo</i> in NB xenograftsYaya Chu, Gaurav Nayyar, Meijuan Tian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor T Cells in Acute Myeloid LeukemiaQuy Le, Sommer Castro, Thao Tang, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Human Gene Therapy|August 10, 2007
Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domainsJinjuan Wang, Michael Jensen, Yukang Lin, et al.
Oncotarget|June 10, 2016
Human HLA-A*02:01/CHM1+ allo-restricted T cell receptor transgenic CD8+ T cells specifically inhibit Ewing sarcoma growth in vitro and in vivoFranziska Blaeschke, Uwe Thiel, Andreas Kirschner, et al.
Molecular Therapy. Oncology|June 27, 2024
Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 <i>in vitro</i> and <i>in vivo</i> in NB xenograftsYaya Chu, Gaurav Nayyar, Meijuan Tian, et al.
Molecular Therapy. Oncology|February 9, 2026
Erratum: Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 <i>in vitro</i> and <i>in vivo</i> in NB xenograftsYaya Chu, Gaurav Nayyar, Meijuan Tian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor T Cells in Acute Myeloid LeukemiaQuy Le, Sommer Castro, Thao Tang, et al.
Pageof 2